ATE386986T1 - Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten - Google Patents

Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten

Info

Publication number
ATE386986T1
ATE386986T1 AT02749828T AT02749828T ATE386986T1 AT E386986 T1 ATE386986 T1 AT E386986T1 AT 02749828 T AT02749828 T AT 02749828T AT 02749828 T AT02749828 T AT 02749828T AT E386986 T1 ATE386986 T1 AT E386986T1
Authority
AT
Austria
Prior art keywords
metabolites
methods
interpret
generate
view
Prior art date
Application number
AT02749828T
Other languages
English (en)
Inventor
Steven Watkins
Original Assignee
Lipomics Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23173313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE386986(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lipomics Technologies Inc filed Critical Lipomics Technologies Inc
Application granted granted Critical
Publication of ATE386986T1 publication Critical patent/ATE386986T1/de

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/20—Heterogeneous data integration
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Theoretical Computer Science (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioethics (AREA)
  • Public Health (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Primary Health Care (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Software Systems (AREA)
  • Artificial Intelligence (AREA)
  • Evolutionary Computation (AREA)
  • Data Mining & Analysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
AT02749828T 2001-07-06 2002-07-05 Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten ATE386986T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30370401P 2001-07-06 2001-07-06

Publications (1)

Publication Number Publication Date
ATE386986T1 true ATE386986T1 (de) 2008-03-15

Family

ID=23173313

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02749828T ATE386986T1 (de) 2001-07-06 2002-07-05 Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten

Country Status (7)

Country Link
US (2) US20040143461A1 (de)
EP (1) EP1417629B1 (de)
AT (1) ATE386986T1 (de)
AU (1) AU2002320316A1 (de)
CA (1) CA2452660A1 (de)
DE (1) DE60225145D1 (de)
WO (1) WO2003005628A2 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2298181C (en) 2000-02-02 2006-09-19 Dayan Burke Goodnough Non-targeted complex sample analysis
AU2002348574A1 (en) * 2001-09-24 2003-04-07 Lipomics Technologies, Inc. Methods of using quantitative lipid metabolome data
CA2477909A1 (en) 2002-03-11 2003-09-25 Lipomics Technologies, Inc. Novel metabolic targets and markers
US7714398B2 (en) * 2002-09-05 2010-05-11 Nanomix, Inc. Nanoelectronic measurement system for physiologic gases and improved nanosensor for carbon dioxide
KR100775659B1 (ko) 2002-03-22 2007-11-15 페노미넘 디스커버리스 인코포레이티드 퓨리에 변환 이온 사이클로트론 공진 질량 분석계로부터 생성된 비표적 메타볼로믹 데이터의 시각화 방법
US9740817B1 (en) 2002-10-18 2017-08-22 Dennis Sunga Fernandez Apparatus for biological sensing and alerting of pharmaco-genomic mutation
US8346482B2 (en) 2003-08-22 2013-01-01 Fernandez Dennis S Integrated biosensor and simulation system for diagnosis and therapy
US20060088860A1 (en) * 2004-09-13 2006-04-27 Lipomics Technologies, Inc. Metabolite markers for weight management
WO2006069268A1 (en) * 2004-12-22 2006-06-29 Pharmacyclics, Inc. System and method for analysis of neurological condition
KR100616611B1 (ko) 2005-03-31 2006-08-25 한국과학기술원 Ｘｍｌ을 이용한 대사흐름분석용 정보 시스템 및 그운용방법
AU2006265381B2 (en) 2005-06-30 2010-06-10 Biocrates Life Sciences Ag Device for quantitative analysis of a metabolite profile
US7949475B2 (en) * 2005-08-08 2011-05-24 Metabolon Inc. System and method for analyzing metabolomic data
SG182169A1 (en) 2005-09-12 2012-07-30 Phenomenome Discoveries Inc Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites
WO2007050318A2 (en) * 2005-10-24 2007-05-03 Duke University Lipidomics approaches for central nervous system disorders
US20080020472A1 (en) * 2005-11-22 2008-01-24 Frantz Biomarkers, Llc Method for detecting an inflammatory disease or cancer
US7491504B2 (en) 2005-11-22 2009-02-17 Frantz Biomarkers, Llc Method for detecting ovarian cancer
US7981399B2 (en) * 2006-01-09 2011-07-19 Mcgill University Method to determine state of a cell exchanging metabolites with a fluid medium by analyzing the metabolites in the fluid medium
US7291502B2 (en) * 2006-03-15 2007-11-06 Franco Wayne P Method for performing a non-invasive blood gas test
EP2008108B1 (de) * 2006-03-24 2010-12-29 Metanomics GmbH MITTEL UND VERFAHREN ZUR PROGNOSE ODER DIAGNOSE VON DIABETES typ II
DK2013619T3 (en) 2006-04-10 2017-12-04 Wisconsin Alumni Res Found METHODS FOR USING HUMAN EMBYO STEM CELLS FOR EVALUATION OF THE PHARMACEUTICAL SUBSTANCE AND OTHER CHEMICALS
US8137977B2 (en) * 2006-04-24 2012-03-20 Children's Hospital & Research Center At Oakland Lipidomic approaches to determining drug response phenotypes in cardiovascular disease
US8498879B2 (en) 2006-04-27 2013-07-30 Wellstat Vaccines, Llc Automated systems and methods for obtaining, storing, processing and utilizing immunologic information of individuals and populations for various uses
WO2007144467A1 (en) * 2006-06-12 2007-12-21 Zora Biosciences Oy Diagnostic method for myopathy
ES2527438T3 (es) 2006-08-08 2015-01-26 Metabolon, Inc. Marcadores de la hepatopatía grasa no alcohólica (NAFLD) y de la esteatohepatitis no alcohólica (NASH) y métodos de uso de los mismos
US20080179301A1 (en) * 2006-08-25 2008-07-31 Guy Garty Systems and methods for etching materials
US9255348B2 (en) 2006-08-25 2016-02-09 The Trustees Of Columbia University In The City Of New York Systems and methods for biodosimetry with biochip using gene expression signatures
EP1923806A1 (de) * 2006-11-14 2008-05-21 Metanomics GmbH Schnelle, metabolomische Analyse und System dafür
WO2008124920A1 (en) * 2007-04-12 2008-10-23 The Governors Of The University Of Alberta Urine based detection of a disease state caused by a pneumococcal infection
CN102105797A (zh) * 2008-05-28 2011-06-22 巴斯夫欧洲公司 用于评估过氧化物酶体增殖的工具和方法
WO2010033816A1 (en) * 2008-09-18 2010-03-25 Ingenix, Inc. Apparatus, system and method for graphically displaying natural history of disease progression
WO2011119637A1 (en) 2010-03-22 2011-09-29 Stemina Biomarker Discovery, Inc. Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomics
EP2385374B2 (de) 2010-05-05 2018-02-28 Zora Biosciences OY Lipidomik-Biomarker für Atherosklerose und kardiovaskuläre Erkrankung
JP5662060B2 (ja) * 2010-06-04 2015-01-28 学校法人帝京大学 検出方法
CA2801459C (en) 2010-06-20 2018-04-24 Zora Biosciences Oy Lipidomic biomarkers for identification of high-risk coronary artery disease patients
US20120078521A1 (en) * 2010-09-27 2012-03-29 General Electric Company Apparatus, system and methods for assessing drug efficacy using holistic analysis and visualization of pharmacological data
US9541565B2 (en) 2011-04-08 2017-01-10 Zora Biosciences Oy Biomarkers for sensitive detection of statin-induced muscle toxicity
KR20140090448A (ko) * 2013-01-09 2014-07-17 한국전자통신연구원 의료 관리 서버 및 그것의 의료 관리 방법
ES2806751T3 (es) 2013-09-26 2021-02-18 Nat Univ Singapore Composiciones y métodos utilizando andamios de lisofosfatidilcolina
JP2017516085A (ja) * 2014-04-08 2017-06-15 メタボルン インコーポレーティッド 疾患診断および健康評価のための個々の対象の低分子生化学プロファイリングの方法
CN105353607B (zh) * 2015-11-26 2017-10-27 江南大学 一种由数据差异驱动的间歇过程自学习动态优化方法
US11036779B2 (en) * 2018-04-23 2021-06-15 Verso Biosciences, Inc. Data analytics systems and methods
JP2020180826A (ja) * 2019-04-24 2020-11-05 株式会社島津製作所 分析データ解析システム
CN112986425B (zh) * 2021-02-09 2023-07-04 首都医科大学 Pm2.5对脂质代谢影响的检测标志物及应用
CN115112776B (zh) * 2021-03-18 2023-07-04 中国科学院大连化学物理研究所 联合标志物及在诊断心房颤动中应用及诊断试剂或试剂盒
CN115774059A (zh) * 2021-09-07 2023-03-10 中国科学院深圳先进技术研究院 一种阿尔兹海默症生物标志物及其筛选方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873726A (en) * 1968-02-14 1975-03-25 Ethyl Corp Method and composition for reducing plasma lipid levels
US3847550A (en) * 1973-03-27 1974-11-12 Atomic Energy Commission Differential chromatographic method
US5075101A (en) * 1990-04-10 1991-12-24 Siguel Edward N Method for diagnosis of fatty acid or lipid abnormalities
US5706603A (en) * 1990-11-16 1998-01-13 E. I. Du Pont De Nemours And Company Production method for corn with enhanced quality grain traits
US5773300A (en) * 1995-05-18 1998-06-30 Cell Therapeutics, Inc. Neoplasia diagnostic method
CZ297289B6 (cs) * 1995-12-21 2006-10-11 Societe Des Produits Nestle S. A. Imortalizované bunecné linie a zivné médium
US5952235A (en) * 1997-04-14 1999-09-14 Case Western Reserve University Detection of teratogen exposure
US6188783B1 (en) * 1997-07-25 2001-02-13 Affymetrix, Inc. Method and system for providing a probe array chip design database
CA2299625A1 (en) * 1997-08-15 1999-02-25 Affymetrix, Inc. Polymorphism detection utilizing clustering analysis
US6222911B1 (en) * 1998-08-05 2001-04-24 Nortel Networks Limited Programmable access carrier selection terminal
US6185561B1 (en) * 1998-09-17 2001-02-06 Affymetrix, Inc. Method and apparatus for providing and expression data mining database
AU2054000A (en) * 1999-02-26 2000-09-14 Lipomed, Inc. Methods, systems, and computer program products for analyzing and presenting risk assessment results based on nmr lipoprotein analysis of blood
WO2002057989A2 (en) * 2001-01-18 2002-07-25 Basf Aktiengesellschaft Method for metabolic profiling

Also Published As

Publication number Publication date
AU2002320316A1 (en) 2003-01-21
EP1417629A2 (de) 2004-05-12
WO2003005628A3 (en) 2003-11-06
EP1417629B1 (de) 2008-02-20
DE60225145D1 (de) 2008-04-03
US20040143461A1 (en) 2004-07-22
US20110172926A1 (en) 2011-07-14
CA2452660A1 (en) 2003-01-16
WO2003005628A2 (en) 2003-01-16
EP1417629A4 (de) 2005-08-17

Similar Documents

Publication Publication Date Title
ATE386986T1 (de) Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten
Wathan et al. Online access to quantitative data resources
Asch Rebuilding Dresden.
Selman GA Adopts Final Document.
Uehling Getting Serious About Biomarkers.
Stateman Nunsense.
Ellyatt Teaching from the Soul.
Humphreys Imagination and historical sense.
Gillon Alastair Vincent Campbell
Schumacher Touched by Disney.
Fringe Addressing workplace issues.
Tomar Remarks on Receiving the Distinguished Service Award.
Parushev Evangelical Scholars address Public Theology.
Goodwine Ocean County Library Receives BlueClaws Grant.
Mino A futuristic vision.
Szabo John Szabo Leads FLA.
Purnell Futures in Geographical Education.
Watras The annual report as a marketing tool.
Smith Implementing the 14-19 reforms.
Cash Postcards from the Edge of Digital.
Wilcox et al. Sharing good practice
Donnelley Kansas on My Mind.
Evans Are Printers Missing a Large-Format Opportunity?
Stewart et al. Tennessee technology student honored
Slusar College of DuPage Announces Online Courses.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties